GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operatio...(----- ----- ----- ----- ...),Health

Date:8/7/2009

----- ----- ----- ----- Other income (expense) Interest income 7 16 17 43 --- --- --- --- 7 16 17 43 --- --- --- --- Net loss $(1,349) $(1,284) $(2,210) $(1,967) ======= ======= ======= ======= Income (loss) per common share $(0.00) $0.00 $(0.00) $(0.00) ====== ===== ====== ======

                                 GEOVAX LABS, INC.
                          Condensed Balance Sheet Information
                               (amounts in thousands)

                                                         June 30,  Dec. 31,
                                                           2009     2008
                                                           ----     ----
     Assets:
       Cash and cash equivalents                          $1,823   $2,191
       Other current assets                                  386      611
                                                             ---      ---
       Total current assets                                2,210    2,802

       Property, net                                         117      139
       Other assets                                          105      115
                                                             ---      ---
       Total assets                                       $2,432   $3,056
                                                          ======   ======

     Liabilities and stockholders' equity
       Current liabilities                                  $333     $346
       Stockholders' equity                                2,099  
'/>"/>
SOURCE  GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 
Related medicine news :

1. GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow
2. Nortech Labs, Inc. and MEDNET(TM) Make for a Notable, Natural Partnership
3. Scarguard Labs, LLC Appoints Richard E. Pino as CFO
4. Scarguard Labs, LLC Expands Distribution Reach Through Agreements With McKesson Drugs and Publix Supermarkets
5. Innovatech Labs, Assisting Companies in Adhering to Halogen-Free Manufacturing Standards Aimed at Protecting the Environment
6. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
7. NATB Announces Partnership With Ronald McDonald House Charities(R)
8. LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
9. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
10. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
11. AMN Healthcare Announces Second Quarter 2009 Results